{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:39:10Z","timestamp":1792370350873,"version":"4.4.0"},"reference-count":187,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.autrev.2024.103534","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:44:38Z","timestamp":1711406678000},"page":"103534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Redox mechanisms in autoimmune thyroid eye disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Francesco","family":"Buonfiglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina A.","family":"Ponto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Gericke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103534_bb0005","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103534_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2011.09.004","article-title":"Prevention of Graves\u2019 ophthalmopathy","volume":"26","author":"Bartalena","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0015","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.survophthal.2021.08.010","article-title":"Thinking inside the box: current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease","volume":"67","author":"Gupta","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.629925","article-title":"Stimulatory thyrotropin receptor antibodies are a biomarker for graves\u2019 orbitopathy","volume":"11","author":"George","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0025","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","article-title":"Thyroid stimulating hormone receptor antibodies in thyroid eye disease-methodology and clinical applications","volume":"34","author":"Diana","year":"2018","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.autrev.2024.103534_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101620","article-title":"Pathophysiology of thyroid-associated orbitopathy","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0035","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1210\/en.2010-0424","article-title":"Neutral antibodies to the TSH receptor are present in Graves\u2019 disease and regulate selective signaling cascades","volume":"151","author":"Morshed","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2024.103534_bb0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40618-020-01353-y","article-title":"Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves\u2019 orbitopathy","volume":"44","author":"Nicol\u00ec","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0045","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1210\/jc.2018-02705","article-title":"High titers of thyrotropin receptor antibodies are associated with orbitopathy in patients with graves disease","volume":"104","author":"Kahaly","year":"2019","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41433-018-0242-9","article-title":"Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy","volume":"33","author":"Roos","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.autrev.2024.103534_bb0055","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/jc.2016-1220","article-title":"Thyroid stimulating antibodies are highly prevalent in Hashimoto\u2019s thyroiditis and associated Orbitopathy","volume":"101","author":"Kahaly","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves\u2019 Orbitopathy","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0065","doi-asserted-by":"crossref","first-page":"5590471","DOI":"10.1155\/2021\/5590471","article-title":"IgG4 as a biomarker in graves\u2019 orbitopathy","volume":"2021","author":"Olejarz","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2024.103534_bb0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41433-022-01981-z","article-title":"Clinical relevance of thyroid-stimulating immunoglobulin as a biomarker of the activity of thyroid eye disease","volume":"37","author":"Jeon","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.autrev.2024.103534_bb0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40618-020-01380-9","article-title":"Thyrotropin receptor antibodies and Graves\u2019 orbitopathy","volume":"44","author":"Diana","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MNM.0000000000001649","article-title":"A retrospective study of clinical features and prognosis of patients with Graves\u2019 disease and ophthalmopathy","volume":"44","author":"Rui","year":"2023","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.autrev.2024.103534_bb0085","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s40618-023-02085-5","article-title":"The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels","volume":"46","author":"Sari\u0107 Matutinovi\u0107","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0090","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019 orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40618-015-0254-2","article-title":"Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy","volume":"38","author":"Ponto","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40618-021-01652-y","article-title":"Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves' orbitopathy","volume":"45","author":"Sari\u0107 Matutinovi\u0107","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/678194","article-title":"Thyroid stimulating but not blocking autoantibodies are highly prevalent in severe and active thyroid-associated orbitopathy: a prospective study","volume":"2015","author":"Kampmann","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12980","article-title":"Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease","volume":"189","author":"Diana","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1089\/thy.2015.0031","article-title":"Prevalence, phenotype, and psychosocial well-being in Euthyroid\/hypothyroid thyroid-associated orbitopathy","volume":"25","author":"Ponto","year":"2015","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.autrev.2024.103534_bb0120","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bjo.2007.137265","article-title":"Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical graves ophthalmopathy","volume":"93","author":"Eckstein","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of thyrotropin receptor antibody-induced signaling cascades","volume":"150","author":"Morshed","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2024.103534_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2024.103534_bb0135","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","article-title":"Thyroid stimulating hormone receptor antibodies in thyroid eye disease\u2014methodology and clinical applications","volume":"34","author":"Diana","year":"2018","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.autrev.2024.103534_bb0140","first-page":"673","article-title":"The thyrotropin (TSH)-releasing hormone receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2024.103534_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jc.2009-2405","article-title":"The Thyrocyte-Fibrocyte link: closing the loop in the pathogenesis of Graves\u2019 disease?","volume":"95","author":"Kahaly","year":"2010","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1062045","article-title":"A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves\u2019 orbitopathy","volume":"14","author":"Cui","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186561","article-title":"Is there evidence for IGF1R-stimulating abs in graves\u2019 orbitopathy pathogenesis?","volume":"21","author":"Krieger","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/jc.2015-2932","article-title":"Reversal of pathological features of Graves' orbitopathy by activation of forkhead transcription factors, FOXOs","volume":"101","author":"Zhang","year":"2016","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","article-title":"The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy","volume":"33","author":"Huang","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.autrev.2024.103534_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that Underly T cell immunity in Graves\u2019 Orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0175","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1172\/JCI117289","article-title":"Retrobulbar T cells from patients with Graves\u2019 ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts","volume":"93","author":"Grubeck-Loebenstein","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0180","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1997.4491347.x","article-title":"Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO)","volume":"109","author":"Pappa","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2249.1998.00613.x","article-title":"Analysis of orbital T cells in thyroid-associated ophthalmopathy","volume":"112","author":"F\u00f6rster","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0190","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2010-1424","article-title":"Regulatory T-cells in Graves\u2019 orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin","volume":"96","author":"Kahaly","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0195","first-page":"911","article-title":"CD4+ T cells and the Th1\/Th2 imbalance are implicated in the pathogenesis of Graves\u2019 ophthalmopathy","volume":"17","author":"Xia","year":"2006","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2024.103534_bb0200","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves\u2019 ophthalmopathy","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0205","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103534_bb0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/tjo.tjo_18_20","article-title":"Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development","volume":"10","author":"Huang","year":"2020","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0215","article-title":"Research progress on the pathogenesis of Graves\u2019 ophthalmopathy: based on immunity, noncoding RNA and exosomes","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0220","doi-asserted-by":"crossref","first-page":"7453260","DOI":"10.1155\/2019\/7453260","article-title":"Immunological aspects of graves\u2019 ophthalmopathy","volume":"2019","author":"\u0141acheta","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2024.103534_bb0225","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1210\/jc.2016-1882","article-title":"IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO","volume":"101","author":"Fang","year":"2016","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0230","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1167\/iovs.16-20199","article-title":"IL-17A promotes RANTES expression, but not IL-16, in orbital fibroblasts via CD40-CD40L combination in thyroid-associated ophthalmopathy","volume":"57","author":"Fang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0235","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2017-01349","article-title":"Regulation of orbital fibrosis and adipogenesis by pathogenic Th17 cells in graves orbitopathy","volume":"102","author":"Fang","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/JOE-11-0488","article-title":"\u03b2 (CCL2) and \u03b1 (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-\u03b1 agonists in Graves\u2019 ophthalmopathy","volume":"213","author":"Antonelli","year":"2012","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0245","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4049\/jimmunol.175.2.1310","article-title":"IL-1\u03b2 induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy","volume":"175","author":"Chen","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0250","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1167\/iovs.13-13759","article-title":"Pirfenidone attenuates the IL-1\u03b2-induced hyaluronic acid increase in orbital fibroblasts from patients with thyroid-associated ophthalmopathy","volume":"55","author":"Chung","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2005-1018","article-title":"T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy","volume":"147","author":"Han","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2024.103534_bb0260","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0002-9440(10)63488-8","article-title":"Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes","volume":"163","author":"Koumas","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2024.103534_bb0265","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.4049\/jimmunol.174.5.3072","article-title":"Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma","volume":"174","author":"Han","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0270","first-page":"1748","article-title":"Research progress in Th17 cells and the relevant cytokines in Graves' ophthalmopathy","volume":"47","author":"Jiang","year":"2022","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.autrev.2024.103534_bb0275","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1167\/iovs.18-24008","article-title":"Interaction between CCR6+ Th17 cells and CD34+ fibrocytes promotes inflammation: implications in graves\u2019 orbitopathy in Chinese population","volume":"59","author":"Fang","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0280","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4049\/jimmunol.1900434","article-title":"Slit2 may underlie divergent induction by thyrotropin of IL-23 and IL-12 in human Fibrocytes","volume":"204","author":"Fernando","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1272\/jnms.79.46","article-title":"Sequential analysis of myofibroblast differentiation and transforming growth factor-\u03b21\/Smad pathway activation in murine pulmonary fibrosis","volume":"79","author":"Usuki","year":"2012","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.autrev.2024.103534_bb0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/17469899.2014.917960","article-title":"Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: from bench to bedside","volume":"9","author":"Rajaii","year":"2014","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0295","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jaci.2018.05.036","article-title":"T cell-intrinsic prostaglandin E(2)-EP2\/EP4 signaling is critical in pathogenic T(H)17 cell-driven inflammation","volume":"143","author":"Lee","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107300","article-title":"Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy","volume":"91","author":"Pan","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2024.103534_bb0305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-065X.2008.00637.x","article-title":"Human regulatory T cells: role in autoimmune disease and therapeutic opportunities","volume":"223","author":"Brusko","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2024.103534_bb0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0042-122780","article-title":"Decreased frequencies of peripheral blood CD4+CD25+CD127-Foxp3+ in patients with graves\u2019 disease and graves\u2019 orbitopathy: enhancing effect of insulin growth Factor-1 on Treg cells","volume":"49","author":"Pawlowski","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0315","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000452541","article-title":"Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases","volume":"40","author":"Li","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.autrev.2024.103534_bb0320","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lfs.2017.11.026","article-title":"Autoimmune thyroid diseases and Th17\/Treg lymphocytes","volume":"192","author":"Shao","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0325","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12020-015-0662-2","article-title":"Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders","volume":"51","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2024.103534_bb0330","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11596-022-2671-8","article-title":"Role of peripheral regulatory T lymphocytes in patients with thyroid associated ophthalmopathy during systemic glucocorticoid treatment: a prospective observational study","volume":"43","author":"Xu","year":"2023","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0335","article-title":"A role of NR4A2 in Graves\u2019 disease: regulation of Th17\/Treg","author":"Zhao","year":"202483432","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2024.103534_bb0340","doi-asserted-by":"crossref","first-page":"E400","DOI":"10.1210\/jc.2011-2697","article-title":"Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves\u2019 ophthalmopathy","volume":"97","author":"van Steensel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0345","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/bjo.2003.035915","article-title":"Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression","volume":"88","author":"Eckstein","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5603\/FHC.a2020.0003","article-title":"Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy","volume":"58","author":"Pawlowski","year":"2020","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.autrev.2024.103534_bb0355","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2008.03219.x","article-title":"Role of macrophage infiltration in the orbital fat of patients with Graves\u2019 ophthalmopathy","volume":"69","author":"Chen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2024.103534_bb0360","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exer.2016.05.005","article-title":"Histamine induces NF-\u03baB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1","volume":"147","author":"Virakul","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0365","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.2021.0464","article-title":"An early wave of macrophage infiltration intertwined with antigen-specific proinflammatory T cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of graves\u2019 orbitopathy","volume":"32","author":"Philipp","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103534_bb0370","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1089\/thy.2022.0254","article-title":"M1-like macrophages modulate fibrosis and inflammation of orbital fibroblasts in graves\u2019 orbitopathy: potential relevance to soluble Interleukin-6 receptor","volume":"33","author":"Lu","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103534_bb0375","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1089\/thy.2022.0173","article-title":"Single-blind, case-control, immunohistochemical study of orbital tissue in thyroid eye disease","volume":"32","author":"Hai","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103534_bb0380","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00417-022-05856-7","article-title":"Elevated expression of interleukin-27, IL-35, and decreased IL-12 in patients with thyroid-associated ophthalmopathy","volume":"261","author":"Zhang","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0385","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/thy.2007.0250","article-title":"Thyroid hormone effects on mitochondrial energetics","volume":"18","author":"Harper","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103534_bb0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/er.2013-1006","article-title":"Thyroid hormone, Thyromimetics, and metabolic efficiency","volume":"35","author":"Yehuda-Shnaidman","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2024.103534_bb0395","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2003-38392","article-title":"Effects of thyroid state on H2O2 production by rat heart mitochondria: sites of production with complex I-and complex II-linked substrates","volume":"35","author":"Venditti","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1113\/eph8802506","article-title":"Regulation of mitochondrial biogenesis by thyroid hormone","volume":"88","author":"Weitzel","year":"2003","journal-title":"Exp Physiol"},{"key":"10.1016\/j.autrev.2024.103534_bb0405","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00204-015-1520-y","article-title":"Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism","volume":"89","author":"Liemburg-Apers","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.autrev.2024.103534_bb0410","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/15548627.2015.1061849","article-title":"Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling","volume":"11","author":"Sinha","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2024.103534_bb0415","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/en.2015-1632","article-title":"Thyroid hormone stimulation of autophagy is essential for mitochondrial biogenesis and activity in skeletal muscle","volume":"157","author":"Lesmana","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2024.103534_bb0420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","article-title":"ROS production by mitochondria: function or dysfunction?","volume":"43","author":"Palma","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.autrev.2024.103534_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2024.103534_bb0430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s42000-020-00173-2","article-title":"Selenium involvement in mitochondrial function in thyroid disorders","volume":"19","author":"Gheorghiu","year":"2020","journal-title":"Hormones"},{"key":"10.1016\/j.autrev.2024.103534_bb0435","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6757154","article-title":"Thyroid hormones, oxidative stress, and inflammation","volume":"2016","author":"Mancini","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2024.103534_bb0440","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/ERC-11-0230","article-title":"Total oxidant\/antioxidant status in sera of patients with thyroid cancers","volume":"18","author":"Wang","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.autrev.2024.103534_bb0445","doi-asserted-by":"crossref","first-page":"545","DOI":"10.20945\/2359-3997000000075","article-title":"Evaluation of redox profiles in exogenous subclinical hyperthyroidism at two different levels of TSH suppression","volume":"62","author":"Piazera","year":"2018","journal-title":"Arch Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0450","doi-asserted-by":"crossref","DOI":"10.5696\/2156-9614-10.27.200903","article-title":"Assessment of thyroid function and oxidative stress state in foundry workers exposed to lead","volume":"10","author":"Fahim","year":"2020","journal-title":"J Health Pollut"},{"key":"10.1016\/j.autrev.2024.103534_bb0455","article-title":"The influence of oxidative stress on thyroid diseases","volume":"10","author":"Kochman","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.autrev.2024.103534_bb0460","first-page":"674","article-title":"Oxidative stress in hypothyroid patients and the role of antioxidant supplementation, Indian","volume":"20","author":"Chakrabarti","year":"2016","journal-title":"J Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0465","article-title":"Hypothyroid women have persistently higher oxidative stress compared to healthy controls","volume":"12","author":"Riis","year":"2023","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.autrev.2024.103534_bb0470","series-title":"Antioxidant Status in Thyroid Dysfunction","author":"Resch","year":"2002"},{"key":"10.1016\/j.autrev.2024.103534_bb0475","doi-asserted-by":"crossref","first-page":"1304315","DOI":"10.3389\/fimmu.2023.1304315","article-title":"Editorial: mitochondrial dysfunction in inflammation and autoimmunity","volume":"14","author":"Staal","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107670","article-title":"Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs","volume":"14","author":"Jing","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103534_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7151","article-title":"Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis","volume":"8","author":"Yang","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2024.103534_bb0490","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/ars.2013.5702","article-title":"Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus","volume":"21","author":"Doherty","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.autrev.2024.103534_bb0495","doi-asserted-by":"crossref","first-page":"725","DOI":"10.20452\/pamw.3592","article-title":"Cigarette smoking: number one enemy for graves ophthalmopathy","volume":"126","author":"Bartalena","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.autrev.2024.103534_bb0500","doi-asserted-by":"crossref","first-page":"1160172","DOI":"10.3389\/fendo.2023.1160172","article-title":"Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysis","volume":"14","author":"Oeverhaus","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103534_bb0505","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves\u2019 ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0510","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.eye.6702603","article-title":"Cigarette smoking and thyroid eye disease: a systematic review","volume":"21","author":"Thornton","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.autrev.2024.103534_bb0515","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/thy.1999.9.297","article-title":"Oxygen free radicals in interleukin-l\u03b2-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and graves\u2019 ophthalmopathy patients","volume":"9","author":"Lu","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103534_bb0520","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-023-03335-5","article-title":"Relationship between smoking and serum levels of eye muscle and orbital connective tissue antibodies in patients with graves ophthalmopathy","author":"Lahooti","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2024.103534_bb0525","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/bjophthalmol-2014-306463","article-title":"Smoking was associated with poor response to intravenous steroids therapy in Graves\u2019 ophthalmopathy","volume":"99","author":"Xing","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0530","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1210\/jc.2016-1279","article-title":"Hypoxia-dependent HIF-1 activation impacts on tissue remodeling in graves\u2019 ophthalmopathy-implications for smoking","volume":"101","author":"G\u00f6rtz","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.608733","article-title":"Antioxidant therapy in Graves\u2019 Orbitopathy","volume":"11","author":"Lanzolla","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0540","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2018-00509","article-title":"Stimulatory TSH-receptor antibodies and oxidative stress in graves disease","volume":"103","author":"Diana","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0545","first-page":"1871","article-title":"The role of oxidative stress and therapeutic potential of antioxidants in graves&rsquo","volume":"9","author":"Hou","year":"2021","journal-title":"Ophthal Biomed"},{"key":"10.1016\/j.autrev.2024.103534_bb0550","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinbiochem.2004.09.015","article-title":"Oxidative stress peripheral parameters in Graves\u2019 disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy","volume":"38","author":"Bednarek","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2024.103534_bb0555","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.imlet.2004.03.020","article-title":"Peripheral parameters of oxidative stress in patients with infiltrative Graves\u2019 ophthalmopathy treated with corticosteroids","volume":"93","author":"Bednarek","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2024.103534_bb0560","first-page":"191","article-title":"Proptosis is associated with thiol-disulfide in patients with Graves' ophthalmopathy","volume":"66","author":"Acibucu","year":"2022","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103534_bb0565","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12886-018-0969-x","article-title":"Oxidative stress markers in tears of patients with Graves\u2019 orbitopathy and their correlation with clinical activity score","volume":"18","author":"Choi","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0570","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/eye.2008.310","article-title":"Oxidative stress in patients with Graves\u2019 ophthalmopathy: relationship between oxidative DNA damage and clinical evolution","volume":"23","author":"Tsai","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.autrev.2024.103534_bb0575","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/archopht.125.12.1652","article-title":"Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy","volume":"125","author":"Tsai","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0580","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2265.2010.03904.x","article-title":"Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves\u2019 ophthalmopathy","volume":"74","author":"Akarsu","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2024.103534_bb0585","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1055\/a-1274-0998","article-title":"The effect of immunosuppression on selected antioxidant parameters in patients with graves\u2019 disease with active thyroid-associated orbitopathy","volume":"129","author":"Londzin-Olesik","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.autrev.2024.103534_bb0590","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/eye.2010.31","article-title":"Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves\u2019 ophthalmopathy: evidence that oxidative stress has a role in this disorder","volume":"24","author":"Tsai","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.autrev.2024.103534_bb0595","first-page":"2782","article-title":"Increased response to oxidative stress challenge in Graves\u2019 ophthalmopathy orbital fibroblasts","volume":"17","author":"Tsai","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.autrev.2024.103534_bb0600","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02713680802123532","article-title":"Oxidative stress and antioxidant activity in orbital fibroadipose tissue in graves\u2019 ophthalmopathy","volume":"33","author":"Hondur","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0605","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem.74.4.1532179","article-title":"Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves\u2019 retroocular fibroblasts","volume":"74","author":"Heufelder","year":"1992","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0610","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/exer.1997.0353","article-title":"Superoxide radical production stimulates retroocular fibroblast proliferation in Graves\u2019 ophthalmopathy","volume":"65","author":"Burch","year":"1997","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0615","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/thy.1999.9.297","article-title":"Oxygen free radicals in interleukin-l\u03b2-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and graves\u2019 ophthalmopathy patients","volume":"9","author":"Lu","year":"1999","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.autrev.2024.103534_bb0620","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/biof.5520190308","article-title":"Oxidative stress and Graves\u2019 ophthalmopathy: in vitro studies and therapeutic implications","volume":"19","author":"Bartalena","year":"2003","journal-title":"BioFactors"},{"key":"10.1016\/j.autrev.2024.103534_bb0625","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/thy.2020.0238","article-title":"Downregulation of caveolin-1 and upregulation of deiodinase 3, Associated with hypoxia-inducible factor-1\u03b1 increase, are involved in the oxidative stress of graves' orbital adipocytes","volume":"31","author":"Van Regemorter","year":"2020","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.autrev.2024.103534_bb0630","first-page":"927","article-title":"The protective effect of antioxidants on orbital fibroblasts from patients with Graves\u2019 ophthalmopathy in response to oxidative stress","volume":"19","author":"Tsai","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.autrev.2024.103534_bb0635","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3390\/antiox12071465","article-title":"Oxidative stress: a suitable therapeutic target for optic nerve diseases?","volume":"12","author":"Buonfiglio","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.autrev.2024.103534_bb0640","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1530\/JME-21-0057","article-title":"PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis","volume":"66","author":"Ko","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0645","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cen.12222","article-title":"Smoking and thyroid","volume":"79","author":"Wiersinga","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2024.103534_bb0650","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/IOP.0000000000001514","article-title":"The effect of smoking on mitochondrial biogenesis in patients with graves ophthalmopathy","volume":"36","author":"Yuksel","year":"2020","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.autrev.2024.103534_bb0655","doi-asserted-by":"crossref","first-page":"4676289","DOI":"10.1155\/2016\/4676289","article-title":"Cigarette smoke extract-induced oxidative stress and fibrosis-related genes expression in orbital fibroblasts from patients with graves\u2019 ophthalmopathy","volume":"2016","author":"Kau","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.autrev.2024.103534_bb0660","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0665","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JOE-12-0257","article-title":"Cigarette smoke extract-induced adipogenesis in Graves\u2019 orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress","volume":"216","author":"Yoon","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2024.103534_bb0670","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac203","article-title":"Macrophage-orbital fibroblast interaction and hypoxia promote inflammation and adipogenesis in graves\u2019 orbitopathy","volume":"164","author":"G\u00f6rtz","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2024.103534_bb0675","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/thy.2015.0087","article-title":"Oxidative stress and upregulation of antioxidant proteins, including adiponectin, in extraocular muscular cells, orbital adipocytes, and thyrocytes in graves' disease associated with orbitopathy","volume":"25","author":"Marique","year":"2015","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.autrev.2024.103534_bb0680","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/ijms23010153","article-title":"miR-199a downregulation as a driver of the NOX4\/HIF-1α\/VEGF-a pathway in thyroid and orbital adipose tissues from graves′ Patients","volume":"23","author":"Craps","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0685","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/en.2018-00272","article-title":"HIF2A\u2013LOX pathway promotes fibrotic tissue remodeling in thyroid-associated orbitopathy","volume":"160","author":"Hikage","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2024.103534_bb0690","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","article-title":"Pathogenesis of thyroid eye disease: review and update on molecular mechanisms","volume":"100","author":"Khong","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0695","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/joco.joco_266_21","article-title":"A systematic review on the role of antioxidants in thyroid eye disease","volume":"34","author":"Akbarian","year":"2022","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0700","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-0029-1220724","article-title":"Selenium and inflammation: underlying anti-inflammatory mechanisms","volume":"41","author":"Duntas","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0705","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(00)02490-9","article-title":"The importance of selenium to human health","volume":"356","author":"Rayman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2024.103534_bb0710","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/thy.2016.0397","article-title":"Antioxidant actions of selenium in orbital fibroblasts: a basis for the effects of selenium in graves\u2019 orbitopathy","volume":"27","author":"Rotondo Dottore","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103534_bb0715","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/IOP.0000000000001931","article-title":"Anti-inflammatory and antioxidant effects of selenium on orbital fibroblasts of patients with graves ophthalmopathy","volume":"37","author":"Kim","year":"2021","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.autrev.2024.103534_bb0720","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103534_bb0725","article-title":"Selenium in the treatment of Graves\u2019 hyperthyroidism and eye disease","volume":"11","author":"Lanzolla","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103534_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121871","article-title":"The role of oxidative stress and therapeutic potential of antioxidants in Graves\u2019 Ophthalmopathy","volume":"9","author":"Hou","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2024.103534_bb0735","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40618-017-0718-7","article-title":"Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?","volume":"41","author":"Rotondo Dottore","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0740","first-page":"11","article-title":"A review on various uses of N-acetyl cysteine","volume":"19","author":"Mokhtari","year":"2017","journal-title":"Cell J (Yakhteh)"},{"key":"10.1016\/j.autrev.2024.103534_bb0745","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"suppl 10","key":"10.1016\/j.autrev.2024.103534_bb0750","article-title":"MTORC1 blockade with rapamycin and N-acetylcysteine reduces anti-phospholipid antibody levels in controlled clinical trials of patients with SLE","volume":"69","author":"Winans","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103534_bb0755","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ebiom.2018.09.033","article-title":"mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease","volume":"36","author":"Perl","year":"2018","journal-title":"eBioMedicine"},{"key":"10.1016\/j.autrev.2024.103534_bb0760","doi-asserted-by":"crossref","DOI":"10.1097\/IN9.0000000000000010","article-title":"Principles behind SLE treatment with N-acetylcysteine","volume":"4","author":"Nasr","year":"2022","journal-title":"Immunometabolism"},{"key":"10.1016\/j.autrev.2024.103534_bb0765","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40618-017-0809-5","article-title":"Antioxidant effects of \u03b2-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO)","volume":"41","author":"Rotondo Dottore","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0770","article-title":"Antioxidant activities of quercetin and its complexes for medicinal application","volume":"24","author":"Xu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.autrev.2024.103534_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026261","article-title":"Quercetin inhibits IL-1\u03b2-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves\u2019 orbitopathy","volume":"6","author":"Yoon","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103534_bb0780","first-page":"521","article-title":"Quercetin decreases proliferation of orbital fibroblasts and their release of hyaluronic acid","volume":"34","author":"Lisi","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0785","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/bjophthalmol-2012-301537","article-title":"Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy","volume":"96","author":"Yoon","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0790","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1167\/iovs.12-9646","article-title":"Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves\u2019 orbitopathy","volume":"53","author":"Yoon","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0795","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40618-023-02024-4","article-title":"Traditional Chinese medicine in thyroid-associated orbitopathy","volume":"46","author":"Hai","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2024.103534_bb0800","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1167\/iovs.19-27376","article-title":"Therapeutic effect of curcumin, a plant polyphenol extracted from Curcuma longae, in fibroblasts from patients with graves' orbitopathy","volume":"60","author":"Lee","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0805","article-title":"Curcumin suppresses TGF-\u03b21-induced myofibroblast differentiation and attenuates angiogenic activity of orbital fibroblasts","volume":"22","author":"Yu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0810","first-page":"13","article-title":"Health benefits of resveratrol administration","volume":"66","author":"Galiniak","year":"2019","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.autrev.2024.103534_bb0815","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of human SIRT1 activation by resveratrol*","volume":"280","author":"Borra","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2024.103534_bb0820","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315105","article-title":"Resveratrol-like compounds as SIRT1 activators","volume":"23","author":"Ciccone","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0825","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1167\/iovs.15-16870","article-title":"Therapeutic effect of resveratrol on oxidative stress in graves\u2019 orbitopathy orbital fibroblasts","volume":"56","author":"Kim","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0830","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1167\/iovs.61.5.64","article-title":"Gypenosides protect orbital fibroblasts in graves ophthalmopathy via anti-inflammation and anti-fibrosis effects","volume":"61(5)","author":"Li","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0835","first-page":"4432584","article-title":"Therapeutic effect of gypenosides on antioxidant stress injury in orbital fibroblasts of graves\u2019 orbitopathy","author":"Ma","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0840","series-title":"Oxidative stress and dietary antioxidants in neurological diseases","first-page":"199","article-title":"Chapter 14 - Berberine neuroprotection and antioxidant activity","author":"Imenshahidi","year":"2020"},{"key":"10.1016\/j.autrev.2024.103534_bb0845","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.63.10.6","article-title":"Potential therapeutic activity of berberine in thyroid-associated ophthalmopathy: inhibitory effects on tissue remodeling in orbital fibroblasts","volume":"63","author":"Diao","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0850","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00011-017-1100-0","article-title":"Astragaloside IV attenuates orbital inflammation in Graves\u2019 orbitopathy through suppression of autophagy","volume":"67","author":"Li","year":"2018","journal-title":"Inflamm Res"},{"key":"10.1016\/j.autrev.2024.103534_bb0855","first-page":"45","article-title":"Icariin inhibits AMPK-dependent autophagy and adipogenesis in adipocytes in vitro and in a model of Graves\u2019 orbitopathy in vivo","volume":"8","author":"Li","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2024.103534_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108894","article-title":"Polydatin attenuates orbital oxidative stress in Graves\u2019 orbitopathy through the NRF2 pathway","volume":"315","author":"Li","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.autrev.2024.103534_bb0865","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1167\/iovs.14-14008","article-title":"Effect of tanshinone IIA in an in vitro model of Graves\u2019 orbitopathy","volume":"55","author":"Rhiu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2024.103534_bb0870","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.2147\/DDDT.S266911","article-title":"Pharmacological activity and mechanism of tanshinone IIA in related diseases","author":"Guo","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.autrev.2024.103534_bb0875","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/608512","article-title":"Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat","volume":"2014","author":"Chandran","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.autrev.2024.103534_bb0880","doi-asserted-by":"crossref","first-page":"R572","DOI":"10.1152\/ajpregu.2000.278.3.R572","article-title":"Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues","volume":"278","author":"de Cavanagh","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.autrev.2024.103534_bb0885","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/thy.2012.0373","article-title":"Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts","volume":"23","author":"Botta","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103534_bb0890","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1389201020666190725113816","article-title":"Clinical features of graves\u2019 ophthalmopathy and impact of enalapril on the course of mild graves\u2019 ophthalmopathy: a pilot study","volume":"20","author":"Ataabadi","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.autrev.2024.103534_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102539","article-title":"Differential endothelial hydrogen peroxide signaling via Nox isoforms: critical roles for Rac1 and modulation by statins","volume":"58","author":"Waldeck-Weiermair","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.autrev.2024.103534_bb0900","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/clinem\/dgab070","article-title":"Statins decrease the risk of orbitopathy in newly diagnosed patients with graves disease","volume":"106","author":"Nilsson","year":"2021","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0905","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S2213-8587(21)00238-2","article-title":"Statins for Graves\u2019 orbitopathy (STAGO): a phase 2, open-label, adaptive, single Centre, randomised clinical trial","volume":"9","author":"Lanzolla","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Issue 10","key":"10.1016\/j.autrev.2024.103534_bb0910","first-page":"CD005262","article-title":"Pentoxifylline for intermittent claudication","author":"Broderick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2024.103534_bb0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192781","article-title":"Promising effects of xanthine oxidase inhibition by allopurinol on autonomic heart regulation estimated by heart rate variability (HRV) analysis in rats exposed to hypoxia and hyperoxia","volume":"13","author":"Zaj\u0105czkowski","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103534_bb0920","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0002-9394(00)00359-7","article-title":"Antioxidant agents in the treatment of Graves\u2019 ophthalmopathy","volume":"129","author":"Bouzas","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0925","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/112067210401400401","article-title":"Pentoxifylline (PTX)-an alternative treatment in Graves\u2019 ophthalmopathy (inactive phase): assessment by a disease specific quality of life questionnaire and by exophthalmometry in a prospective randomized trial","volume":"14","author":"Finamor","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.autrev.2024.103534_bb0930","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.82.6.9995","article-title":"Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO): a pilot study","volume":"82","author":"Balazs","year":"1997","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103534_bb0935","first-page":"173","article-title":"Inhibitory effect of pentoxifylline on HLA-DR expression and glycosaminoglycan synthesis of retrobulbar fibroblasts induced by interferon gamma","volume":"44","author":"Balazs","year":"1997","journal-title":"Acta Microbiol Immunol Hung"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T19:54:15Z","timestamp":1731614055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":187,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1568997224000259"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103534","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox mechanisms in autoimmune thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103534"}}